Insulet
PODD
#1128
Rank
A$24.83 B
Marketcap
$354.14
Share price
0.24%
Change (1 day)
33.70%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.46 B

According to Insulet's latest financial reports the company's current earnings (TTM) are A$0.45 B. In 2023 the company made an earning of A$0.37 B an increase over its 2022 earnings that were of A$64.64 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.46 B22.61%
2023 A$0.37 B481.9%
2022 A$64.64 M-45.24%
2021 A$0.11 B43.35%
2020 A$82.34 M18.51%
2019 A$69.48 M41.16%
2018 A$49.22 M-711.95%
2017 -A$8.05 M-56.85%
2016 -A$18.65 M-79.31%
2015 -A$90.13 M63.85%
2014 -A$55.01 M31.04%
2013 -A$41.98 M-21.96%
2012 -A$53.79 M
2010 -A$51.3 M-42.38%
2009 -A$89.04 M-33.56%
2008 -A$0.14 B65.93%
2007 -A$80.76 M209.75%
2006 -A$26.08 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.01 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.21 B-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.23 B 169.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.40 B 6,518.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.76 B 2,025.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.46 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$13.48 B 2,834.80%๐Ÿ‡บ๐Ÿ‡ธ USA